COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,384 Articles (22,816 medRxiv, 8,568 bioRxiv)

Most recent first Previous |  Page 1052: Articles 10511-10520  | Next

IL4I1 binds to TMPRSS13 and competes with SARS-Cov2 Spike
Gatineau, J., Nidercorne, C., Dupont, A., Puiffe, M.-L., Cohen, J. L., Molinier-Frenkel, V., Niedergang, F., Castellano, F.
10.1101/2021.12.23.473686 — Posted: 2021-12-25
Human KIR+CD8+ T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19
Li, J., Zaslavsky, M. E., Su, Y., Sikora, M., van Unen, V., Christophersen, A., Chiou, S.-H., Chen, L., Li, J., Ji, X., Wilhelmy, J., McSween, A., Palanski, B. A., Mallajosyula, V., Dhondalay, G., Bhamidipati, K., Pai, J., Kipp, L., Dunn, J., Hauser, S., Oksenberg, J., Satpathy, A., Robinson, W., Steinmetz, L., Khosla, C., Utz, P., Sollid, L. M., Heath, J., Fernandez-Becker, N., Nadeau, K., Saligrama, N., Davis, M.
10.1101/2021.12.23.473930 — Posted: 2021-12-25
SARS-CoV-2 comes up with a perfect recipe for disaster: Each mutation plays a specific role in the evolution of variants of concern
Upadhyay, V., Patrick, C., Lucas, A., Mallela, K.
10.1101/2021.12.23.474050 — Posted: 2021-12-25
Designing multi-epitope based peptide vaccine targeting spike protein SARS-CoV-2 B1.1.529 (Omicron) variant using computational approaches.
Parmar, M., Thumar, R., Sheth, J., Patel, D.
10.1101/2021.12.23.473990 — Posted: 2021-12-25
Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening.
Tanaka, T., Saito, A., Suzuki, T., Miyamoto, Y., Takayama, K., Okamoto, T., Moriishi, K.
10.1101/2021.12.23.474055 — Posted: 2021-12-25
Are COVID-19 data reliable? The case of the European Union
Kolias, P.
10.1101/2021.12.24.21268373 — Posted: 2021-12-25 Discussion: Onsite
Risk of myocarditis following sequential COVID-19 vaccinations by age and sex
Patone, M., Mei, W. X., Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., Watkinson, P., Khunti, K., Harnden, A., Coupland, C. A., Channon, K. M., Mills, N. L., Sheikh, A., Hippisley-Cox, J.
10.1101/2021.12.23.21268276 — Posted: 2021-12-25 Discussion: Onsite
A novel methodology for the synchronous collection and multimodal visualisation of continuous neurocardiovascular and neuromuscular physiological data in adults with long COVID
Xue, F., Monaghan, A., Jennings, G., Byrne, L., Foran, T., Duggan, E., Romero-Ortuno, R.
10.1101/2021.12.24.21268370 — Posted: 2021-12-25
Genomic diversification of long polynucleotide fragments is a signature of emerging SARS-CoV-2 variants of concern
Murugadoss, K., Niesen, M. J., Raghunathan, B., Lenehan, P. J., Ghosh, P., Feener, T., Anand, P., Simsek, S., Suratekar, R., Hughes, T. K., Soundararajan, V.
10.1101/2021.12.23.21268315 — Posted: 2021-12-25 Discussion: Onsite
Influenza A H1N1 mediated pre-existing immunity to SARS-CoV-2 predicts COVID-19 outbreak dynamics
Martin Almazan, N., Rahbar, A., Carlsson, M., Hoffman, T., Kolstad, L., Ronnberg, B., Russel Pantalone, M., Lewensohn Fuchs, I., Naucler, A., Ohlin, M., Sacharczuk, M., Religa, P., Amer, S., Molnar, C., Lundkvist, A., Susrud, A., Sorensen, B., Soderberg-Naucler, C.
10.1101/2021.12.23.21268321 — Posted: 2021-12-25 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).